Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml

• Matteo Ferro ,

  Contributed equally to this work with: Matteo Ferro, Dario Bruzzese

  Affiliations Urology Unit, University “Federico II”, Naples, Italy, Division of Urology, European Institute of Oncology, Milan, Italy

  ⨯
• Dario Bruzzese ,

  Contributed equally to this work with: Matteo Ferro, Dario Bruzzese

  Affiliation Department of Preventive Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Sisto Perdonà,

  Affiliation Urology Unit, Fondazione G. Pascale, Napoli, Italy

  ⨯
• Ada Marino,

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Claudia Mazzarella,

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Giuseppe Perruolo,

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Vittoria D’Esposito,

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Vincenzo Cosimato,

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯
• Carlo Buonerba,

  Affiliation Oncology Unit, University “Federico II”, Naples, Italy

  ⨯
• Giuseppe Di Lorenzo,

  Affiliation Oncology Unit, University “Federico II”, Naples, Italy

  ⨯
• Gennaro Musi,

  Affiliation Division of Urology, European Institute of Oncology, Milan, Italy

  ⨯
• Ottavio De Cobelli,

  Affiliation Division of Urology, European Institute of Oncology, Milan, Italy

  ⨯
• Felix K. Chun,

  Affiliation Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

  ⨯
• Daniela Terracciano

  * E-mail: daniela.terracciano@unina.it

  Affiliation Department of Translational Medical Sciences, University “Federico II”, Naples, Italy

  ⨯